JP2020535203A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535203A5 JP2020535203A5 JP2020518033A JP2020518033A JP2020535203A5 JP 2020535203 A5 JP2020535203 A5 JP 2020535203A5 JP 2020518033 A JP2020518033 A JP 2020518033A JP 2020518033 A JP2020518033 A JP 2020518033A JP 2020535203 A5 JP2020535203 A5 JP 2020535203A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- nucleotide sequence
- sequence encoding
- fragment
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2017-0127550 | 2017-09-29 | ||
| KR20170127550 | 2017-09-29 | ||
| PCT/KR2018/011529 WO2019066556A1 (ko) | 2017-09-29 | 2018-09-28 | 심장 부정맥의 예방 또는 치료용 약학적 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535203A JP2020535203A (ja) | 2020-12-03 |
| JP2020535203A5 true JP2020535203A5 (https=) | 2021-11-04 |
| JP7178118B2 JP7178118B2 (ja) | 2022-11-25 |
Family
ID=65902177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518033A Active JP7178118B2 (ja) | 2017-09-29 | 2018-09-28 | 不整脈を予防または治療するための医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11761019B2 (https=) |
| EP (1) | EP3689363A4 (https=) |
| JP (1) | JP7178118B2 (https=) |
| KR (2) | KR102916658B1 (https=) |
| CN (1) | CN111542334B (https=) |
| WO (1) | WO2019066556A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102712841B1 (ko) * | 2017-09-29 | 2024-10-04 | (주)벳바젠 | 심부전의 예방 또는 치료용 약학적 조성물 |
| KR20240173703A (ko) * | 2023-06-05 | 2024-12-13 | (주)벳바젠 | 포스포람반의 단백질 포스파타아제 1-매개 탈인산화 억제용 데코이 펩타이드를 암호화하는 뉴클레오타이드 및 ccn5 단백질 또는 이의 단편을 암호화하는 뉴클레오타이드를 포함하는 유전자 컨스트럭트 및 이의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US20090239940A1 (en) | 1997-07-22 | 2009-09-24 | Del Monte Federica | Treating heart failure and ventricular arrhythmias |
| EP1382347A1 (en) * | 2002-07-17 | 2004-01-21 | UNIVERSITE PARIS 7 - Denis DIDEROT | Use of CCN protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux |
| US20040106954A1 (en) * | 2002-11-15 | 2004-06-03 | Whitehurst Todd K. | Treatment of congestive heart failure |
| WO2006007444A2 (en) | 2004-06-16 | 2006-01-19 | The Trustees Of Columbia University In The City Of New York | CaMKII/CALCIUM CHANNEL BINDING-RELATED COMPOSITIONS AND METHODS |
| KR101187814B1 (ko) | 2010-03-22 | 2012-10-08 | 광주과학기술원 | 심부전 예방 또는 치료용 약제학적 조성물 및 심부전 예방 또는 치료제의 스크리닝 방법 |
| CN105452458A (zh) * | 2013-06-07 | 2016-03-30 | 加利福尼亚大学董事会 | 用于治疗心力衰竭和增加心脏功能的不能产生环腺苷酸的腺苷酸环化酶和组合物和方法 |
| JP6726291B2 (ja) | 2015-11-13 | 2020-07-22 | ベスファジェン・インコーポレイテッドＢｅｔｈｐｈａｇｅｎ Ｉｎｃ． | 心筋線維化の処置のための医薬組成物 |
-
2018
- 2018-09-28 EP EP18861445.7A patent/EP3689363A4/en active Pending
- 2018-09-28 JP JP2020518033A patent/JP7178118B2/ja active Active
- 2018-09-28 WO PCT/KR2018/011529 patent/WO2019066556A1/ko not_active Ceased
- 2018-09-28 CN CN201880077650.2A patent/CN111542334B/zh active Active
- 2018-09-28 US US16/651,889 patent/US11761019B2/en active Active
- 2018-09-28 KR KR1020180115954A patent/KR102916658B1/ko active Active
-
2019
- 2019-07-16 KR KR1020190085741A patent/KR102916659B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518268A5 (https=) | ||
| ES2387082T3 (es) | Uso de OSTEOPONTINA para el tratamiento y/o prevención de enfermedades neurológicas | |
| JP2020203894A5 (https=) | ||
| JP2020073536A5 (https=) | ||
| JP2011525363A5 (https=) | ||
| US20040009939A1 (en) | Methods of enhancing immune induction involving MDA-7 | |
| JP2018524393A5 (https=) | ||
| JP2020519292A5 (https=) | ||
| RU2019100525A (ru) | Векторная система на основе аденоассоциированного вируса | |
| US20240002462A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| JP2006502702A5 (https=) | ||
| RU2019126509A (ru) | Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе | |
| JP2017523239A5 (https=) | ||
| JP2004501650A5 (https=) | ||
| JP2021533801A5 (https=) | ||
| JP2020535203A5 (https=) | ||
| IL298772A (en) | Coding-optimized nucleic acid encoding the SMN1 protein and its use | |
| JP2018509154A5 (https=) | ||
| Guo et al. | Molecular cloning and characterization of a novel bovine IFN-ε | |
| US20150118187A1 (en) | Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof | |
| JP2006511212A5 (https=) | ||
| JP2020536519A5 (https=) | ||
| RU2639582C2 (ru) | Композиция для предупреждения или лечения бокового амиотрофического склероза с использованием двух или более изоформ фактора роста гепатоцитов | |
| CN107073078B (zh) | 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物 | |
| RU2020114946A (ru) | Фармацевтическая композиция для профилактики или лечения аритмии сердца |